Biosynth extends its offering to multi-kilogram GMP peptide synthesis through the acquisition of Pepceuticals finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
The acquisition of multi-kilogram GMP and fill-finish capabilities enables the support of all phases of the product life cycle from discovery to commercialisation.STAAD, Switzerland (BUSINESS WIRE) Biosynth, a supplier of critical materials to the life science industry, is pleased to announce the acquisition of Pe.
Biosynth announces today that its site in Lelystad, The Netherlands, successfully passed the recent GMP inspection by the Inspectie Gezondheidszorg en Jeugd (IGJ) on January 25, 2023. The scope of the inspection was the Quality Management System of the site. The inspection, carried out by the IGJ confirmed the .